15.63 USD
-0.45 (-2.8%)
15.63 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to SGRY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.52. This target is 69.67% above the current price.
SGRY was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about SGRY.
In the previous month the buy percentage consensus was at a similar level.
SGRY was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-13 | UBS | Maintains | Buy -> Buy |
| 2025-11-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-11 | Benchmark | Maintains | Buy -> Buy |
| 2025-10-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-27 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-21 | Benchmark | Reiterate | Buy -> Buy |
| 2025-03-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-11 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-12-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-11-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-19 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-11-13 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-11-04 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-10-14 | UBS | Initiate | Buy |
| 2024-10-11 | Keybanc | Initiate | Sector Weight |
| 2024-10-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-26 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-07 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-07 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-28 | Macquarie | Initiate | Outperform |
| 2024-05-08 | Citigroup | Maintains | Buy -> Buy |
SURGERY PARTNERS INC / SGRY FAQ
What do analysts expect the price target to be for SURGERY PARTNERS INC (SGRY)?
18 analysts have analysed SGRY and the average price target is 26.52 USD. This implies a price increase of 69.67% is expected in the next year compared to the current price of 15.63.
How do analysts rate SURGERY PARTNERS INC (SGRY)?
The consensus rating for SURGERY PARTNERS INC (SGRY) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.